Introduction
The pharmaceutical market is dynamic and influenced by various factors, including regulatory changes, market demand, and competitive landscape. This article focuses on the market analysis and price projections for Pantoprazole Sodium, specifically the NDC 31722-0204, which is a product of Camber Pharmaceuticals.
Drug Overview
Pantoprazole Sodium, with the NDC 31722-0204, is a proton pump inhibitor (PPI) used to treat conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other stomach acid-related disorders. It is available in various forms, including vials for intravenous administration.
Current Market Prices
As of the latest data, the prices for Pantoprazole Sodium 40 mg vials (NDC 31722-0204) have shown a trend of fluctuation but overall stability.
| Date |
Price/Unit ($) |
| 2024-12-18 |
2.33707 |
| 2024-11-20 |
2.42509 |
| 2024-10-23 |
2.52578 |
| 2024-09-18 |
2.52578 |
| 2024-08-21 |
2.62250 |
| 2024-07-17 |
2.96633[1]. |
Regulatory Impact
The pharmaceutical industry is heavily influenced by regulatory changes. The Biden-Harris Administration's recent initiatives to negotiate lower drug prices for Medicare beneficiaries are significant. Although Pantoprazole Sodium is not among the first 10 drugs selected for the Medicare drug price negotiation program, future expansions of such programs could impact its pricing.
For instance, the administration's efforts have resulted in negotiated prices that cut the list prices of selected drugs by 38 to 79 percent. This trend could set a precedent for future price negotiations, potentially affecting a broader range of medications, including Pantoprazole Sodium[2].
Market Trends
The pharmaceutical market is experiencing several key trends that could influence the pricing and demand for Pantoprazole Sodium:
Specialty Pharmaceuticals
Specialty pharmaceuticals, including those for chronic conditions, are driving a projected 3.8% increase in drug prices. While Pantoprazole Sodium is not classified as a specialty drug, the overall inflation in the pharmaceutical market can indirectly affect its pricing[4].
Prevention and Personalization
The industry is shifting towards prevention and personalized medicine, with a focus on data-driven, customized treatments. This trend might not directly impact the pricing of Pantoprazole Sodium but could influence the broader market dynamics and patient preferences[3].
Policy and Regulatory Changes
Policy changes, such as those proposed in the President’s Budget for Fiscal Year 2025, aim to curb inflation in prescription drug prices and expand cost caps. These changes can create a more competitive pricing environment and may affect the pricing strategies of pharmaceutical companies[2].
Price Projections
Given the current trends and regulatory environment, here are some key points to consider for price projections:
- Short-term Stability: The prices of Pantoprazole Sodium have been relatively stable over the past year, with minor fluctuations. This stability is likely to continue in the short term.
- Long-term Impact of Regulatory Changes: Future expansions of Medicare price negotiation programs and other regulatory initiatives could lead to lower prices for a wider range of medications, including potentially Pantoprazole Sodium.
- Market Inflation: The overall increase in pharmaceutical prices, driven by specialty drugs and other factors, might lead to a slight increase in the prices of non-specialty drugs like Pantoprazole Sodium.
Competitive Landscape
Camber Pharmaceuticals, the manufacturer of Pantoprazole Sodium under NDC 31722-0204, operates in a competitive market. The presence of generic and brand-name competitors can influence pricing strategies. However, as a generic product, Pantoprazole Sodium is generally priced lower than its brand-name counterparts, making it a cost-effective option for patients.
Supply Chain and Demand
Managing pharmacy expenditures and strengthening the supply chain are critical, especially given the challenges faced by hospitals and healthcare providers in recent years, such as drug shortages and rising costs. A stable supply chain and consistent demand can help maintain price stability for Pantoprazole Sodium[4].
Conclusion
The market analysis for Pantoprazole Sodium (NDC 31722-0204) indicates a stable pricing environment in the short term, with potential long-term impacts from regulatory changes and market trends.
Key Takeaways
- Current Prices: Stable with minor fluctuations.
- Regulatory Impact: Future price negotiations and policy changes could lower prices.
- Market Trends: Overall pharmaceutical market inflation and shifts towards prevention and personalization.
- Competitive Landscape: Generic product with competitive pricing.
- Supply Chain: Stability crucial for maintaining price consistency.
FAQs
Q: What is the current price of Pantoprazole Sodium 40 mg vials (NDC 31722-0204)?
A: As of December 2024, the price per unit is approximately $2.33707[1].
Q: How do regulatory changes affect the pricing of Pantoprazole Sodium?
A: Regulatory initiatives like the Medicare drug price negotiation program could lead to lower prices if expanded to include more medications[2].
Q: What are the key trends in the pharmaceutical market that could impact Pantoprazole Sodium?
A: Trends include specialty pharmaceutical-driven price increases, a focus on prevention and personalization, and policy changes aimed at curbing price inflation[3][4].
Q: Who is the manufacturer of Pantoprazole Sodium under NDC 31722-0204?
A: Camber Pharmaceuticals[5].
Q: How does the competitive landscape influence the pricing of Pantoprazole Sodium?
A: As a generic product, it is generally priced lower than brand-name counterparts, making it a cost-effective option[5].
Sources
- Drug Patent Watch - Latest pharmaceutical drug prices and trends for NDC 31722-0204.
- The White House - Fact Sheet: Biden-Harris Administration Announces New, Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation.
- PwC - Pharma industry trends: Five transformative trends shaping 2025 and beyond.
- Vizient Inc. - Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
- FindACode - Camber Pharmaceuticals - List of Drugs - NDC Labeler/Manufacturer.
